AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

MEDICAL DEVELOPMENTS INTERNA

0.465

0.000

Volume:1.62K

Turnover:754.00

Market Cap:52.39M

PE:581.25

High:0.465

Open:0.465

Low:0.465

Close:0.465

52wk High:0.940

52wk Low:0.420

Shares:112.66M

Float Shares:81.69M

Volume Ratio:0.09

T/O Rate:0.00%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.001

EPS(LYR):0.001

ROE:0.19%

ROA:0.14%

PB:0.95

PE(LYR):581.25

Loading ...

Overview Company News Filings

Concept

Pharmaceutical Companies-10.98%

Capital Flow

Inflow:

Outflow:

News

BRIEF-Vaxxas Appoints Former Merck Global Vaccines President David Peacock As CEO

Medical Developments International Limited (ASX:MVP) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough

Simply Wall St.

Vaxxas Appoints Veteran Vaccine Leader to Board as Company Advances Needle-Free Vaccine Patch Towards Market

THOMSON REUTERS

Medical Developments International Limited's (ASX:MVP) Share Price Boosted 27% But Its Business Prospects Need A Lift Too

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/MVP.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MVP.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MVP.AU\",,,,,undefined,":{"symbol":"MVP.AU","market":"AU","secType":"STK","nameCN":"MEDICAL DEVELOPMENTS INTERNA","latestPrice":0.465,"timestamp":1770765288753,"preClose":0.465,"halted":0,"volume":1622,"delay":0,"changeRate":0,"nameEN":"MEDICAL DEVELOPMENTS INTERNA","floatShares":81690477,"shares":112658324,"eps":0.0008,"marketStatus":"Trading","change":0,"latestTime":"02-11 10:33:37 AEDT","open":0.465,"high":0.465,"low":0.465,"amount":754,"amplitude":0,"askPrice":0.475,"askSize":4052,"bidPrice":0.465,"bidSize":394,"shortable":3,"etf":0,"ttmEps":0.0008,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1770786000000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.465,"openAndCloseTimeList":[[1770764400000,1770786000000]],"volumeRatio":0.091313,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MVP.AU\",,,,,undefined,":{"symbol":"MVP.AU","floatShares":81690477,"roa":"0.14%","roe":"0.19%","lyrEps":0.0008,"volumeRatio":0.091313,"shares":112658324,"dividePrice":0,"high":0.465,"amplitude":0,"preClose":0.465,"low":0.465,"week52Low":0.42,"pbRate":"0.95","psRate":"1.34","week52High":0.94,"institutionHeld":0,"latestPrice":0.465,"committee":-0.822762,"eps":0.0008,"divideRate":0,"volume":1622,"delay":0,"ttmEps":0.0008,"open":0.465,"prevYearClose":0.555,"prevWeekClose":0.45,"prevMonthClose":0.47,"prevQuarterClose":0.555,"fiveDayClose":0.485,"twentyDayClose":0.575,"sixtyDayClose":0.58,"dividendPayoutRate":6.922810661128418,"dividendGrowthYears":1,"dividendGrowthRate":1,"fiveYearAvgDividendRate":0.004752121965724171},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MVP.AU\",params:#limit:5,,,undefined,":[{"date":"2025-08-21","symbol":"MVP.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755734400000,"name":null,"time":"","dateTimestamp":1755698400000,"actualEps":null},{"date":"2025-02-20","symbol":"MVP.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740006000000,"name":null,"time":"","dateTimestamp":1739970000000,"actualEps":null},{"date":"2024-08-26","symbol":"MVP.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724630400000,"name":null,"time":"","dateTimestamp":1724594400000,"actualEps":null},{"date":"2024-02-29","symbol":"MVP.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1709161200000,"name":null,"time":"","dateTimestamp":1709125200000,"actualEps":null},{"date":"2023-08-31","symbol":"MVP.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1693440000000,"name":null,"time":"","dateTimestamp":1693404000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MVP.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MVP.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2601611806","title":"BRIEF-Vaxxas Appoints Former Merck Global Vaccines President David Peacock As CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2601611806","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601611806?lang=en_us&edition=fundamental","pubTime":"2026-01-07 21:51","pubTimestamp":1767793867,"startTime":"0","endTime":"0","summary":"BRIEF-Vaxxas Appoints Former Merck Global Vaccines President David Peacock As CEOJan 7 (Reuters) - Medical Developments International Ltd MVP.AX:VAXXAS APPOINTS FORMER MERCK GLOBAL VACCINES PRESIDENT ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nTUA6YKPJL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934455194.USD","LU2361044949.HKD","SG9999015358.SGD","IE00BN8TJ469.HKD","LU0122379950.USD","SG9999002232.USD","IE00BBT3K403.USD","LU1934455863.HKD","LU2361044865.SGD","LU1989771016.USD","LU1934455277.USD","LU1201861249.SGD","LU2089984988.USD","LU0130102774.USD","IE00B4R5TH58.HKD","LU0289739699.SGD","IE0009355771.USD","LU1917777945.USD","SG9999013999.USD","LU2112291526.USD","LU1066051811.HKD","IE00BJJMRZ35.SGD","LU2360032135.SGD","IE000M9KFDE8.USD","LU0211331839.USD","IE0002141913.USD","IE00BJT1NW94.SGD","LU0320765489.SGD","BK4550","IE00BSNM7G36.USD","LU1116320901.HKD","LU2461242641.AUD","LU1093756325.SGD","LU1162221912.USD","LU1941712264.USD","LU0477156953.USD","BK4007","LU1585245621.USD","LU2125154935.USD","LU1035773651.USD","LU0980610538.SGD","LU0965508806.USD","LU1941712348.USD","LU2023250843.SGD","LU1430594728.SGD","SG9999014567.USD","LU0130517989.USD","IE00BLSP4239.USD","LU0058720904.USD","LU0861579265.USD","LU0098860793.USD","LU1291159041.SGD","SG9999001176.SGD","LU1066051498.USD","LU2468319806.SGD","LU1989772923.USD","LU1699723380.USD","LU0203345920.USD","LU1974910355.USD","LU0238689110.USD","LU0320765646.SGD","LU0965509101.SGD","SG9999001176.USD","BK4588","LU1057294990.SGD","LU1929549753.HKD","BK4516","LU0265550946.USD","SG9999015341.SGD","BK4585","LU1066051225.USD","LU1023059063.AUD","IE00BFTCPJ56.SGD","LU0006306889.USD","SG9999001440.SGD","LU2125154778.USD","LU2106854487.HKD","LU0208291251.USD","BK7096","LU1983299246.USD","LU1989772840.SGD","LU0266013472.USD","SG9999014575.USD","LU2361045086.USD","BK4533","LU1061106388.HKD","IE00BLSP4452.SGD","LU2023250504.SGD","LU1069347547.HKD","IE00B1BXHZ80.USD","SG9999002224.SGD","LU1037948897.HKD","SGXZ57979304.SGD","BK4534","LU0265550359.USD","LU0965509010.AUD","LU1037948541.HKD","LU0234572021.USD","LU1116320737.USD","LU0965509283.SGD","LU1093756168.USD","LU0985320562.USD","MVP.AU","LU0106261372.USD","LU0203347892.USD","IE00B2B36J28.USD","BK4559","LU1066053197.SGD","SG9999014542.SGD","LU1571399168.USD","BK7508","LU0070302665.USD","LU0648001328.SGD","SG9999014559.SGD","LU2324357040.USD"],"gpt_icon":0},{"id":"2588709057","title":"Medical Developments International Limited (ASX:MVP) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough","url":"https://stock-news.laohu8.com/highlight/detail?id=2588709057","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588709057?lang=en_us&edition=fundamental","pubTime":"2025-12-02 04:04","pubTimestamp":1764619449,"startTime":"0","endTime":"0","summary":"Medical Developments International Limited ( ASX:MVP ) shares have had a horrible month, losing 27% after a relatively...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-mvp/medical-developments-international-shares/news/medical-developments-international-limited-asxmvp-looks-inex","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-mvp/medical-developments-international-shares/news/medical-developments-international-limited-asxmvp-looks-inex","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MVP","BK7508","MVP.AU","BK7096"],"gpt_icon":0},{"id":"2582791488","title":"Vaxxas Appoints Veteran Vaccine Leader to Board as Company Advances Needle-Free Vaccine Patch Towards Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2582791488","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582791488?lang=en_us&edition=fundamental","pubTime":"2025-11-10 21:00","pubTimestamp":1762779602,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nTUA9SYCPY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MVP.AU","BK7508","BK7096"],"gpt_icon":0},{"id":"2575396768","title":"Medical Developments International Limited's (ASX:MVP) Share Price Boosted 27% But Its Business Prospects Need A Lift Too","url":"https://stock-news.laohu8.com/highlight/detail?id=2575396768","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575396768?lang=en_us&edition=fundamental","pubTime":"2025-10-16 04:25","pubTimestamp":1760559953,"startTime":"0","endTime":"0","summary":"The Medical Developments International Limited ( ASX:MVP ) share price has done very well over the last month, posting...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-mvp/medical-developments-international-shares/news/medical-developments-international-limiteds-asxmvp-share-pri","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-mvp/medical-developments-international-shares/news/medical-developments-international-limiteds-asxmvp-share-pri","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7096","BK7508","MVP","MVP.AU"],"gpt_icon":0}],"pageSize":4,"totalPage":4,"pageCount":1,"totalSize":15,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/MVP.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"Pharmaceutical Companies","bkCode":"BK7508","id":"package_au_concept_yyswg","changeRate":-0.109758}]}}